Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case–control study

Hiroki Namikawa,Makoto Niki,Mamiko Niki,Koichi Yamada,Kiyotaka Nakaie,Arata Sakiyama,Ken-Ichi Oinuma,Taishi Tsubouchi,Yoshihiro Tochino,Yasuhiko Takemoto,Yukihiro Kaneko,Taichi Shuto,Hiroshi Kakeya
DOI: https://doi.org/10.1007/s10096-019-03676-y
2019-10-11
Abstract:<span><em class="EmphasisTypeItalic">Klebsiella pneumoniae</em> bacteremia is a critical clinical presentation that is associated with high mortality. However, extremely few studies have investigated the virulence factors related to mortality of <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia in patients. The present study elucidated clinical and virulence factors associated with the 30-day mortality of <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia at a tertiary hospital. The medical records of 129 patients with <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia admitted to Osaka City University Hospital between January 2012 and December 2018 were retrospectively reviewed. Patient background characteristics, antimicrobial regimens, and prognosis were evaluated. Additionally, virulence factors were assessed using multiplex polymerase chain reaction to elucidate their association with <em class="EmphasisTypeItalic">K. pneumoniae</em>. The 30-day mortality was 10.9% in patients with <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia. The male-to-female ratio, age, and underlying disease did not differ between the non-survivor and survivor groups. Multivariate analysis showed that sepsis (odds ratio (OR), 7.46; <em class="EmphasisTypeItalic">p</em> = 0.005) and <em class="EmphasisTypeItalic">iutA</em> (OR, 4.47; <em class="EmphasisTypeItalic">p</em> = 0.046) were independent predictors associated with the 30-day mortality of <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia. Despite the relatively low 30-day mortality of patients with <em class="EmphasisTypeItalic">K. pneumoniae</em> bacteremia, the treatment of those with sepsis and those infected with <em class="EmphasisTypeItalic">K. pneumoniae</em> harboring <em class="EmphasisTypeItalic">iutA</em> may require careful management for improving their outcomes.</span>
infectious diseases,microbiology
What problem does this paper attempt to address?